Plasmapheresis Market

How Will the Plasmapheresis Market Reach $2.55 Billion by 2030?

PlasmapheresisMarket2023-2030 The plasmapheresis market is projected to reach $2.55 billion by 2030, growing at a CAGR of 8.6% from 2023 to 2030, as indicated by the latest publication from Meticulous Research . This impressive growth is primarily driven by the increasing prevalence of autoimmune diseases, a rising demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. Furthermore, there is a notable surge in demand for plasmapheresis services in emerging economies, which is expected to create significant growth opportunities in the market. Request For Sample Report: https://www.meticulousresearch.com/request-sample- report/cp_id=3092? However, the market faces challenges due to the high costs associated with plasmapheresis devices and procedures. Additionally, the risks linked to these procedures can impede market expansion. Another significant hurdle is the general lack of awareness regarding plasmapheresis and the limited accessibility and availability of these services in certain regions. Future Outlook of the Plasmapheresis Market The plasmapheresis market is categorized by various parameters including product type, technology, application, end user, and geography. The analysis also provides insights into industry competitors and a detailed examination of both country and regional-level markets. In terms of product categories, the disposables segment is anticipated to hold the largest market share in 2023. This dominance is attributed to the frequent use of plasma separation filters and administration sets in plasmapheresis procedures, emphasizing the need for reliable disposable products in clinical settings. From a technological perspective, the centrifugation segment is expected to lead the market in 2023 due to its effectiveness in quickly separating plasma from other blood components. This efficiency is crucial in healthcare settings where time and accuracy are paramount. Application Segmentation The application segment sees the source plasma collection category projected to dominate the market in 2023. This trend is largely driven by the growing demand for source plasma from pharmaceutical and biotechnology companies, coupled with an increased awareness surrounding voluntary plasma donations and the necessity for plasma proteins. Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

PlasmapheresisMarket2023-2030 When it comes to end users, the source plasma collection segment is again expected to lead the market in 2023. The growing requirement for source plasma to manufacture plasma-derived products using plasma fractionation techniques is a key factor contributing to this trend. Geographic Insights This research report examines the plasmapheresis market across key regions, providing a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is projected to capture the largest share of the plasmapheresis market, followed by Europe and Asia-Pacific. The primary reasons for North America's significant market share include heightened awareness of the therapeutic applications of plasmapheresis, a high prevalence of autoimmune diseases, the adoption of advanced technologies, and a robust healthcare infrastructure. Key Players in the Market Prominent players operating within the plasmapheresis market include Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc. (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland). These companies are crucial in driving innovations and advancements in the plasmapheresis market, thereby enhancing the overall growth prospects. Buy Now: https://www.meticulousresearch.com/Checkout/79432394? About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

PlasmapheresisMarket2023-2030 data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com